← Insider buys
BCRX

BioCryst Pharmaceuticals, Inc. · Healthcare

CFO Anthony Doyle bought $440K of BioCryst Pharmaceuticals, Inc.

Bought$440,020
$12.48Price
35,258Shares
+60%Stake

What BCRX did for a copier

Prices for BCRX after this filing aren't in yet.

Anthony Doyle's record

2 other buys on record. A record shows here once 3 of them have 3 months of prices.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Tue, Nov 23. Filed Wed, Nov 24, 6:35 PM ET, after the close. Not investment advice.